MedinCell: Mirova exceeds 5% of voting rights
The declarant stated that it held 2,055,476 MedinCell shares representing the same number of voting rights, i.e. 7.07% of the capital and 5.01% of the voting rights of this pharmaceutical company specializing in long-acting injectable products.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction